A
AGILENT TECHNOLOGIES, INC.
NYSE · Healthcare · Medical - Diagnostics & Research · US
$176.79
+0.76%Year over year
Reported trailing growth
- Revenue
- +8.6%
- EBITDA
- +13.2%
- EBIT
- +13.5%
- EPS
- +18.9%
- Free cash flow
- +32.0%
- Operating cash flow
- +7.6%
Forward estimates
Based on analyst estimates
- Revenue
- +8.4%
- EBITDA
- +24.8%
- EPS
- +31.7%
Three-year CAGR
- Revenue
- +0.5%
- EBITDA
- -1.2%
- EBIT
- -2.9%
- Net income
- +1.3%
- EPS
- +3.1%
- Free cash flow
- +4.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jul 1, 2026